Med Spa Marketing Budget Guide

Define an approved consultation objective
Inventory claims and image permissions
Review forms and measurement data
Price production and ongoing responsibilities
Report consultation progress and misunderstandings

Attributed historical spending references from a May 2025 AmSpa-hosted article by Growth99 CEO Rob Pickell. Full underlying report methodology not reviewed; not agency fees or recommended allocations.
Reference in article	Reported amount	Limitation
Average attributed to AmSpa 2024 report	About 7 percent of revenue	Historical summary; not a current fee quote.
Broad variation described by the author	2 to 15 percent	Range context and methodology not independently established here.

Table source

Begin with an approved consultation objective

Consider a fictional medical aesthetic practice that has opened additional consultation appointments on two afternoons. It wants people to understand its existing services and request a conversation with the practice. It has not introduced a new treatment, changed its clinicians' qualifications, or established that every interested person is suitable for a procedure.

The marketing brief should describe that limited objective. Identify the services the practice has approved for promotion, the actual consultation process, the provider information that can be published, and the appointment capacity available. Avoid turning the campaign into a promise that every consultation will lead to treatment.

This distinction affects the budget. A consultation campaign may need a clear service overview, accurate provider biographies, approved photographs, and a reliable request route. It does not automatically need a large library of treatment-result advertisements. Price the materials required for the actual decision a prospective patient is being invited to make.

Read industry spending references with their limitations

A May 2025 article published by the American Med Spa Association and written by Growth99's CEO discusses marketing spend of roughly 7 percent of revenue on average, citing AmSpa's 2024 industry report. The article also describes a broad 2 to 15 percent range. These are attributed historical references from that article, not Dappr research or a current agency fee schedule.

The underlying report methodology and full marketing tables were not independently examined for this guide. The article also contains provider recommendations and hypothetical business examples. Do not combine those different forms of information into a precise promise about what a practice should spend or how many patients it will gain.

For a purchasing decision, ask what the proposed fee covers and what the practice must supply. A mature practice with approved content and a functioning request process may need different work from a practice rebuilding those foundations. Any allocation based on revenue should be assessed with the practice's qualified financial adviser and its own records.

Budget for a claim inventory before creative production

Create a list of the claims the campaign may communicate: what the service is, who provides it, what the consultation involves, and what expectations the practice can responsibly describe. Have the clinical lead identify approved language and the supporting sources. A writer should not improvise claims about safety, suitability, downtime, or results to make a headline more compelling.

The FDA's aesthetic-device overview notes that results may not match a person's expectations, effects may be temporary, and devices carry risks. This is a reason to preserve qualified review and balanced context. It is not a substitute for the practice's assessment of a particular service, device, or patient.

The marketing estimate should include the time needed to prepare drafts, receive review, and implement corrections. A high monthly content count is not useful if clinical reviewers cannot examine the work. Establish a manageable queue and an approval owner before promising a continuous stream of new treatment pages.

Treat images as claims that also need permission

The FTC's health-products guidance explains that pictures and other presentation choices can communicate implied claims, even when the written copy avoids a direct promise. A striking before-and-after image can therefore require more review than an ordinary office photograph. A small disclaimer is not a general solution to an otherwise misleading message.

For the fictional practice, begin with truthful images of the space and approved team photographs if those assets support the consultation objective. Do not manufacture patient transformations with stock images, editing, or generated imagery. Where real patient material is considered, the practice must address permission, privacy, context, and claim review before publication.

Price those responsibilities explicitly. Who identifies usable material? Who confirms permission? Who approves the crop, caption, and surrounding explanation? Who removes material if its permitted use changes? A content package that excludes these tasks can leave the practice with a large volume of creative it cannot responsibly publish.

Define what the request page is allowed to collect

The initial contact route should explain what happens next and collect only information approved for that purpose. A general marketing form should not become an improvised medical history questionnaire. If the practice needs clinical intake, it should use a process and system approved by its qualified team.

Privacy review should occur before adding advertising tags, chat tools, recordings, or automated transfers. HHS's online-tracking guidance contains both discussion of regulated entities and an explicit notice that a court vacated part of its treatment of certain unauthenticated public webpages. The practice's advisers should determine the requirements for the actual implementation rather than relying on a blanket claim.

Document which data each tool receives, who can access it, and what the marketing report needs. Dappr's own CRM is not presented as a medical record system or as proof of healthcare compliance. Any proposed connection, automation, or data handling must have a separately confirmed scope and appropriate review.

Make offer terms understandable before a campaign starts

If the practice promotes a consultation offer, specify the approved conditions and explain the difference between a consultation and treatment. Have the practice review any stated price, deposit, cancellation term, or time limit. Marketing should not invent an expiring discount to pressure someone into a clinical decision.

Check the entire route from advertisement to page to staff response. A carefully worded website does not help if the advertisement implies a guaranteed result or the acknowledgement sounds like treatment approval. Send reviewers the complete experience, including images, captions, automated messages, and the destination page.

Assign a person to maintain the offer after launch. If appointment availability changes or a provider is unavailable, update the campaign promptly. The ongoing marketing scope should cover factual maintenance, because an accurate offer can become misleading when the underlying operating facts change.

Separate production, management, media, and review costs

A setup estimate may include service-page revisions, provider interviews, approved photography, request-flow testing, and a measurement plan. A recurring agreement may include campaign management, content maintenance, reporting, and coordination with the practice. These are different responsibilities and should be listed clearly.

Media spend, specialist review, software, photography sessions, and other vendor charges may sit outside the agency fee. Confirm who contracts for them and who approves changes. The owner should be able to understand the total planned assignment without discovering essential costs only after the campaign is scheduled.

Also account for practice time. Someone must answer factual questions, review claims, approve creative, and explain appointment outcomes. If that person is unavailable, the project schedule changes. A reasonable scope identifies these dependencies instead of treating every delay as a reason to publish unreviewed material.

Measure consultation progress without optimizing for treatment pressure

Use an approved sequence such as request received, response made, consultation scheduled, and consultation attended. Treatment decisions should remain separate and clinically appropriate. A campaign should not be judged by whether staff can persuade every person who asks a question to purchase a procedure.

An original fictional example illustrates the reporting distinction. Suppose $2,000 of media spend produces 50 requests. Twenty consultations are scheduled, and fifteen have occurred by the review date, with five still pending. Advertising cost per request is $40, while advertising cost per attended consultation is about $133.33 at that provisional date.

These are invented arithmetic inputs, not a med spa benchmark or a Dappr outcome. They exclude management fees, staff work, clinical costs, and revenue. The five pending consultations should remain visible. Do not turn that incomplete cohort into a lifetime-value forecast or assume that an attended consultation creates a particular treatment sale.

Review misunderstandings and operational limits

For the fictional practice, staff might find that people believe the consultation includes a treatment when it does not. That is a communication problem to investigate. They might instead find that suitable appointment times are unavailable. That points to a capacity issue. Those findings require different actions from simply increasing advertising spend.

Use aggregate feedback that the practice has approved for marketing review. Avoid copying sensitive patient stories into a broadly shared presentation. The report can identify a recurring misunderstanding without revealing the individual's medical circumstances or using their experience as promotional material.

At each review, record what will change, who approves it, and when it will be checked again. Preserve the current limitations of the evidence. A small group of inquiries can reveal a broken form or unclear offer, but it cannot establish a dependable long-term acquisition cost or prove a treatment's effectiveness.

Place Dappr plans in the broader assignment

Dappr publishes starting monthly plans of $3,500 for Signal, $6,500 for Momentum, $10,000 for Command, and $15,000 for Fractional CMO. These prices describe broader marketing capacity. They are not med spa treatment prices, a promise of patient volume, or a healthcare compliance package.

Bring the practice's approved services, available appointments, current assets, and named reviewers to a scope discussion. Confirm which marketing work is supported, what the practice retains responsibility for, and which outside costs apply. No medical qualification, clinical outcome, or privacy certification is inferred from Dappr's marketing role.

Questions before you begin

Should a med spa budget start with a treatment-sales target?

Begin by defining an appropriate marketing objective and the consultation process the practice can support. Clinical suitability and treatment decisions remain with qualified professionals. Do not assume every inquiry should become a procedure or use marketing pressure to close that gap.

Are published med spa spending percentages agency prices?

No. Historical revenue percentages, provider advice, and agency fees are different measures. Check the source, date, scope, and methodology. The amount a practice should allocate requires its own operating and financial assessment.

Can before-and-after images be treated like ordinary design assets?

They need review for permissions, privacy, context, and the claims the full presentation communicates. Do not fabricate or alter transformations to imply patient results. The practice's qualified reviewers should approve the specific image and surrounding message.

What should a consultation campaign report?

Use approved definitions for requests, responses, scheduled consultations, attended consultations, and pending outcomes. Keep clinical treatment decisions separate. Label which costs are included and avoid projecting revenue from a form submission.

Does Dappr certify med spa advertising or patient-data compliance?

No such certification or expertise is claimed. The practice needs qualified clinical, legal, and privacy review for its own requirements. Marketing tools and any connections must be scoped and reviewed before implementation.